The Rabbit Polyclonal anti-RIMKLB antibody is suitable to detect RIMKLB in samples from Human, Mouse, Rat and Monkey. It has been validated for WB and ELISA.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:5000,Not yet tested in other applications.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Expiry Date
12 months
Target
RIMKLB
(Ribosomal Modification Protein RimK-Like Family Member B (RIMKLB))
Alternative Name
FAM80B
Background
RIMKLB, FAM80B, KIAA1238, Beta-citryl-glutamate synthase B, N-acetyl-aspartyl-glutamate synthetase B, NAAG synthetase B, NAAGS, Ribosomal protein S6 modification-like protein BRIMKLB is a Protein Coding gene. Among its related pathways are Metabolism and Alanine, aspartate and glutamate metabolism. Beta-citryl-glutamate synthase B catalyzes the synthesis of beta-citryl-L-glutamate and N-acetyl-L-aspartyl-L-glutamate. Beta-citryl-L-glutamate is synthesized more efficiently than N-acetyl-L-aspartyl-L-glutamate. GO annotations related to this gene include glutathione synthase activity and citrate-L-glutamate ligase activity. An important paralog of this gene is RIMKLA.